Angelini has been rapped under the UK pharma industry’s code of practice for criticising licensing decisions made by the EMA and other breaches.
Moderna in talks with FDA over Phase 4 Covid vaccine data
Moderna said it’s working with US regulators to provide post-marketing data on its Covid-19 vaccines that could restore their use to a wider group after


